Logo image of ERA.PA

ERAMET (ERA.PA) Stock Fundamental Analysis

EPA:ERA - Euronext Paris - Matif - FR0000131757 - Common Stock - Currency: EUR

53.8  -1.95 (-3.5%)

Fundamental Rating

4

Taking everything into account, ERA scores 4 out of 10 in our fundamental rating. ERA was compared to 38 industry peers in the Metals & Mining industry. There are concerns on the financial health of ERA while its profitability can be described as average. ERA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

ERA had negative earnings in the past year.
ERA had a negative operating cash flow in the past year.
In multiple years ERA reported negative net income over the last 5 years.
Each year in the past 5 years ERA had a positive operating cash flow.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B

1.2 Ratios

ERA has a Return On Assets of -0.44%. This is in the lower half of the industry: ERA underperforms 65.79% of its industry peers.
ERA has a worse Return On Equity (-1.88%) than 65.79% of its industry peers.
The Return On Invested Capital of ERA (1.55%) is worse than 60.53% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ERA is significantly above the industry average of 6.28%.
The last Return On Invested Capital (1.55%) for ERA is well below the 3 year average (11.73%), which needs to be investigated, but indicates that ERA had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.44%
ROE -1.88%
ROIC 1.55%
ROA(3y)5.62%
ROA(5y)0.67%
ROE(3y)25.94%
ROE(5y)-4.74%
ROIC(3y)11.73%
ROIC(5y)8.92%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60 -80

1.3 Margins

In the last couple of years the Profit Margin of ERA has grown nicely.
With a Operating Margin value of 3.68%, ERA is not doing good in the industry: 60.53% of the companies in the same industry are doing better.
ERA's Operating Margin has declined in the last couple of years.
ERA has a Gross Margin of 66.44%. This is amongst the best in the industry. ERA outperforms 92.11% of its industry peers.
ERA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.68%
PM (TTM) N/A
GM 66.44%
OM growth 3Y-25.05%
OM growth 5Y-24.15%
PM growth 3YN/A
PM growth 5Y18.7%
GM growth 3Y-1.38%
GM growth 5Y19.66%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

ERA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ERA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ERA has more shares outstanding
Compared to 1 year ago, ERA has a worse debt to assets ratio.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

ERA has an Altman-Z score of 1.28. This is a bad value and indicates that ERA is not financially healthy and even has some risk of bankruptcy.
ERA's Altman-Z score of 1.28 is on the low side compared to the rest of the industry. ERA is outperformed by 71.05% of its industry peers.
A Debt/Equity ratio of 1.27 is on the high side and indicates that ERA has dependencies on debt financing.
ERA has a worse Debt to Equity ratio (1.27) than 86.84% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACC0.18
WACC8.76%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

2.3 Liquidity

ERA has a Current Ratio of 2.08. This indicates that ERA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ERA (2.08) is better than 73.68% of its industry peers.
ERA has a Quick Ratio of 1.66. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
ERA's Quick ratio of 1.66 is amongst the best of the industry. ERA outperforms 81.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.66
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

More info and screens

4

3. Growth

3.1 Past

ERA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -119.24%.
ERA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.49% yearly.
ERA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.19%.
The Revenue has been decreasing by -2.69% on average over the past years.
EPS 1Y (TTM)-119.24%
EPS 3YN/A
EPS 5Y15.49%
EPS Q2Q%-142.48%
Revenue 1Y (TTM)-22.19%
Revenue growth 3Y5.2%
Revenue growth 5Y-2.69%
Sales Q2Q%-9.48%

3.2 Future

ERA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.76% yearly.
Based on estimates for the next years, ERA will show a small growth in Revenue. The Revenue will grow by 3.39% on average per year.
EPS Next Y-35.51%
EPS Next 2Y2.24%
EPS Next 3Y26.76%
EPS Next 5YN/A
Revenue Next Year-9.72%
Revenue Next 2Y-1.16%
Revenue Next 3Y3.36%
Revenue Next 5Y3.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ERA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 7.91, which indicates a rather cheap valuation of ERA.
Based on the Price/Forward Earnings ratio, ERA is valued cheaply inside the industry as 84.21% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.72. ERA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.91
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

89.47% of the companies in the same industry are more expensive than ERA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.88
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

ERA's earnings are expected to grow with 26.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.24%
EPS Next 3Y26.76%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.56%, ERA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.64, ERA pays a bit more dividend than its industry peers.
ERA's Dividend Yield is comparable with the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 2.56%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
ERA.PA Yearly Dividends per shareERA.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 1 2 3

5.3 Sustainability

DP0%
EPS Next 2Y2.24%
EPS Next 3Y26.76%
ERA.PA Yearly Income VS Free CF VS DividendERA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M

More info and screens

ERAMET

EPA:ERA (3/21/2025, 7:00:00 PM)

53.8

-1.95 (-3.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)04-24 2025-04-24
Inst Owners11.15%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap1.55B
Analysts80
Price Target84.15 (56.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.56%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.2%
PT rev (3m)-4.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-38.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.91
P/S 0.5
P/FCF N/A
P/OCF N/A
P/B 0.97
P/tB 1.35
EV/EBITDA 3.88
EPS(TTM)-1.07
EYN/A
EPS(NY)6.8
Fwd EY12.64%
FCF(TTM)-22.84
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS107.75
BVpS55.39
TBVpS39.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.44%
ROE -1.88%
ROCE 2.14%
ROIC 1.55%
ROICexc 2.19%
ROICexgc 2.48%
OM 3.68%
PM (TTM) N/A
GM 66.44%
FCFM N/A
ROA(3y)5.62%
ROA(5y)0.67%
ROE(3y)25.94%
ROE(5y)-4.74%
ROIC(3y)11.73%
ROIC(5y)8.92%
ROICexc(3y)17.25%
ROICexc(5y)12.97%
ROICexgc(3y)20.4%
ROICexgc(5y)15.29%
ROCE(3y)16.5%
ROCE(5y)12.5%
ROICexcg growth 3Y-19.97%
ROICexcg growth 5Y-24.81%
ROICexc growth 3Y-19.75%
ROICexc growth 5Y-24.91%
OM growth 3Y-25.05%
OM growth 5Y-24.15%
PM growth 3YN/A
PM growth 5Y18.7%
GM growth 3Y-1.38%
GM growth 5Y19.66%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 4.61
Cap/Depr 202.16%
Cap/Sales 21.14%
Interest Coverage 0.66
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.08
Quick Ratio 1.66
Altman-Z 1.28
F-Score3
WACC8.76%
ROIC/WACC0.18
Cap/Depr(3y)182%
Cap/Depr(5y)147.41%
Cap/Sales(3y)13.6%
Cap/Sales(5y)13.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.24%
EPS 3YN/A
EPS 5Y15.49%
EPS Q2Q%-142.48%
EPS Next Y-35.51%
EPS Next 2Y2.24%
EPS Next 3Y26.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.19%
Revenue growth 3Y5.2%
Revenue growth 5Y-2.69%
Sales Q2Q%-9.48%
Revenue Next Year-9.72%
Revenue Next 2Y-1.16%
Revenue Next 3Y3.36%
Revenue Next 5Y3.39%
EBIT growth 1Y-72.6%
EBIT growth 3Y-21.15%
EBIT growth 5Y-26.19%
EBIT Next Year181.88%
EBIT Next 3Y68.43%
EBIT Next 5YN/A
FCF growth 1Y-267.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-100.24%
OCF growth 3Y-12.93%
OCF growth 5Y-14.13%